FDA AD REGULATION HAMPERED BY PERCEPTION OF "UNEVEN" ENFORCEMENT -- APCO's PINES; "MAJOR STATEMENT" OF RISKS SHOULD BE CONSIDERED TO REPLACE "BRIEF SUMMARY"
Executive Summary
FDA needs to address the persistent perception within industry that enforcement of advertising regulations is inconsistent, APCO Associates Health Care Practice President Wayne Pines told a Food & Drug Law Institute meeting in Costa Mesa, Calif. April 7.